Read + Share
Chaudhary N, Chibly AM, Collier A, Martinalbo J, et al. CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation
prevalence and more altered genomic landscape. NPJ Breast Cancer 2024;10:15.
PMID: 38388477
|
 |
|
Chaudhary N, Chibly AM, Collier A, Martinalbo J, et al. CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation
prevalence and more altered genomic landscape. NPJ Breast Cancer 2024;10:15.
PMID: 38388477
|
|
|
|